Description

BSE permits trading of 2,60,000 new equity shares of Uravi Defence and Technology Limited issued through warrant conversion, effective August 25, 2025.

Summary

BSE has approved the listing and trading of 2,60,000 new equity shares of Uravi Defence and Technology Limited (Scrip Code: 543930) arising from warrant conversion. The shares will commence trading on August 25, 2025, and rank pari-passu with existing equity shares.

Key Points

  • 2,60,000 equity shares of Rs. 10/- each issued at Rs. 320/- premium
  • Issue price: Rs. 330/- per share
  • Allotted to Non Promoters on preferential basis
  • ISIN: INE568Z01015
  • Distribution numbers: 11000001 to 11260000
  • Trading commences August 25, 2025

Regulatory Changes

No regulatory changes. Standard listing procedure for warrant conversion.

Compliance Requirements

  • Trading members informed of new securities availability
  • Lock-in restrictions apply to all allotted shares
  • Shares rank equally with existing equity shares

Important Dates

  • Allotment Dates:
    • February 18, 2025: 140,000 shares
    • February 19, 2025: 60,000 shares
    • March 4, 2025: 60,000 shares
  • Trading Commencement: August 25, 2025
  • Lock-in Expiry: February 25-26, 2026 (varies by tranche)

Impact Assessment

Minimal market impact expected. The warrant conversion represents a small equity dilution for existing shareholders. Lock-in restrictions ensure gradual market entry of new shares over the next 6 months.

Impact Justification

Routine listing of converted warrants with limited market impact